ALEJANDRO ARROLIGA to Nitric Oxide
This is a "connection" page, showing publications ALEJANDRO ARROLIGA has written about Nitric Oxide.
Connection Strength
0.278
-
Update in ARDS management: recent randomized controlled trials that changed our practice. Cleve Clin J Med. 2006 Mar; 73(3):217-9, 223-5, 229 passim.
Score: 0.052
-
Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. Free Radic Biol Med. 2004 Oct 01; 37(7):1010-7.
Score: 0.048
-
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004 Nov; 18(14):1746-8.
Score: 0.047
-
High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung. 2001; 179(4):233-43.
Score: 0.037
-
Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol. 1999 Sep; 21(3):311-6.
Score: 0.033
-
Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med. 1998 Sep; 158(3):917-23.
Score: 0.031
-
Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. Clin Transl Sci. 2008 Sep; 1(2):99-106.
Score: 0.016
-
Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1342-7.
Score: 0.014